Carregant...

Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes

Previous studies showed that antagonists of bombesin (BN)/gastrin-releasing peptide (GRP) inhibit the growth of various cancers by interfering with the growth-stimulatory effects of BN-like peptides and down-regulating epidermal growth factor receptors on tumors. Because the overexpression of the hu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bajo, Ana M., Schally, Andrew V., Krupa, Magdalena, Hebert, Francine, Groot, Kate, Szepeshazi, Karoly
Format: Artigo
Idioma:Inglês
Publicat: The National Academy of Sciences 2002
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC122610/
https://ncbi.nlm.nih.gov/pubmed/11891317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.052715299
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!